CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity.

Documenti analoghi

• Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease.
  di: Patick, A K, et al.
  Pubblicazione: (1996)
• Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus protease.
  di: Reich, S H, et al.
  Pubblicazione: (1995)
• Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease.
  di: Lamarre, D, et al.
  Pubblicazione: (1997)
• ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.
  di: Kempf, D J, et al.
  Pubblicazione: (1995)
• Binding Kinetics of Darunavir to Human Immunodeficiency Virus Type 1 Protease Explain the Potent Antiviral Activity and High Genetic Barrier
  di: Dierynck, Inge, et al.
  Pubblicazione: (2007)